DeSci Ep #4: Decentralizing Drug Development—with Paul Kohlhaas & Tyler Golato of Molecule

Under the current centralized system, drug development happens in silos.  Pharmaceutical companies don’t share information. Scientists run the same failed experiments over and over again. And the process of bringing a drug to market typically takes ten-plus years.  But Paul Kohlhaas and Tyler Golato are building a new way to do drug development. A system that allows for collaboration and dramatically increases the speed of breakthroughs in healthcare.  CEO Paul and CSO Tyler are the Cofounders of Molecule, a decentralized biotech protocol that establishes a Web3 marketplace for research-related intellectual property.  On this episode of Boost VC, Paul and Tyler join us to explain how their personal experiences with the failures of healthcare inspired their interest in changing the system.  They discuss Molecule's end-to-end ecosystem for bringing drugs to market, describing how their IP-NFT both protects innovation and makes it more open, sharable and collaborative.  Listen in for insight on Eroom's Law and learn how open science leads to enormous efficiency gains in the drug development process. Topics Covered How Paul & Tyler define scienceEmpirical discovery of knowledgeProgressive search for truth What inspired Paul & Tyler’s interest in sciencePersonal experience with failures of healthcarePotential for DeSci to foster new behaviors Paul & Tyler’s failed experiment with crowdfundingTried to raise money for microdosing studyPartnership with University of Toronto How Molecule has evolved since 2019Ecosystem for bringing drugs to marketIP-NFT framework for collaboration How to make scientists more open to sharingImprove user experienceStreamline funding process The power of Molecule’s IP-NFT frameworkIntellectual property rights held on chainCollectively owned by patients The value prop for open scienceCreates enormous efficiency gainsMakes drug development much cheaper Jack Scannel’s naming of Eroom’s LawTechnology to discover drugs improvingYet drug discovery output in decline The goals for DeSci over the next decadeExtend quality of human health spanMake science self-sovereign, self-aware How Paul & Tyler define successRemain true to values and vision for lifeNet positive impact on every person Connect with Paul Kohlhaas & Tyler Golato Molecule https://www.molecule.to/Molecule on GitHub https://github.com/moleculeprotocolMolecule on Discord https://discord.com/invite/uAGW7K4hQUMolecule on YouTube https://www.youtube.com/channel/UCWYW5ho3L_d0EO_a619E7RQMolecule on LinkedIn https://www.linkedin.com/company/molecule-protocol  Molecule on Twitter https://twitter.com/molecule_daoPaul on Twitter https://twitter.com/paulkhlsTyler on Twitter https://twitter.com/GolatoTyler Resources Linum Labs https://www.linumlabs.com/Molecule’s Crowdfunding Experiment with the University of Toronto https://www.molecule.to/blog/psychedelics-on-the-blockchainNIH Grants and Funding https://www.nih.gov/grants-fundingSimon de la Rouviere on Bonding Curves https://www.youtube.com/watch?v=-k4M6QAW2pMJack Scannell on Eroom’s Law https://refoundable.com/research/life-after-erooms-law-interview-with-jack-scannell.htmlMeme Lordz https://memelordz.io/North American Association of Technology Transfer http://aim.autm.net/Ray Kurzweil https://www.kurzweilai.net/Peter Diamandis https://www.diamandis.com/Abundance 360 https://www.abundance360.com/summit Connect with Boost VC Boost VC Website https://www.boost.vc/Boost VC on Facebook https://www.facebook.com/boostvc/Boost VC on Twitter https://twitter.com/BoostVCBoost VC on Instagram https://www.instagram.com/boost_vc/